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As the island of knowledge expands, so too do the shores of ignorance.
—Author unknown
Off-pump coronary artery bypass (OFFCAB) has been adoptedenthusiastically by many surgeons throughout the world, butdespite more than 5 years’ experience and progressive refinementof techniques and equipment, many surgeons use it only sporad-ically and some use it hardly at all. This reluctance persists despitethe insistence by many of OFFCAB’s advocates that it can be
performed regularly by any competent surgeon without compromising the safety
and sustained improvement that are hallmarks of the standard operation.
It has never been clear whether the reluctance of many surgeons to adopt
OFFCAB is due to their unwillingness to struggle with a tedious technique even
though it has “obvious” benefits, or whether, as others have insisted, there is still
insufficient evidence to show that its modest benefits are worth all the trouble.1,2 The
comprehensive and thoughtful article in this issue of the Journal by Mack and
associates3 expands our understanding of these issues, but it also highlights our
ignorance.
Mack and associates3 conducted a retrospective review of a 5-year experience
with 12,540 patients who underwent isolated coronary artery bypass grafting
(CABG), of whom 1915 underwent OFFCAB. In the introduction to their report,
they ask four questions that frame the core of our uncertainties about OFFCAB:
1. Can off-pump surgery be safely incorporated into a surgical practice and be
performed by most surgeons?
2. Is there a significant learning curve to the adoption of beating-heart surgery?
3. Does incorporation of off-pump surgery into a surgical practice lead to better
overall outcomes?
4. Are the improved outcomes reported with beating-heart surgery related to the
technique or to individual surgeon experience and expertise?
I would make two additions to this list. As a corollary to question 4, I would also
ask: What is the evidence for better outcomes with beating-heart surgery? I would
also add a question 5: Are the risk models in the Society of Thoracic Surgeons (STS)
National Database, which are derived from experience with on-pump CABG, valid
for assessing risk for patients undergoing OFFCAB?
To answer question 1, Mack and associates3 commendably analyzed the work of
36 surgeons individually, which unfortunately is rarely done in surgical reports. The
number 36 is artifactually inflated by staffing turnover, as there are currently 22
surgeons in the practice. It turns out that the same 6 surgeons who were early,
enthusiastic adopters of OFFCAB (“high adopters”) carried out 73% of all OFFCAB
procedures, whereas the remaining surgeons did OFFCAB sporadically, and 8
surgeons still do fewer than 10 OFFCAB cases per year (“low adopters”). In the
5-year period before the introduction of OFFCAB, the composite mortality rate for
CABG of the 3 lowest adopters was 38% greater than the composite mortality rate
of the 3 highest adopters (4.0% vs 2.9%, P  .001). Clearly, OFFCAB was being
performed predominantly by the most accomplished surgeons. If, as common sense
suggests, this group’s experience is typical, the answer to question 1 is that although
OFFCAB can be safely incorporated into a large practice, it appears unlikely, at
least for now, that OFFCAB will be done regularly by most surgeons. This is true
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even in a trailblazing program in which low adopters can
study the technique in house, without having to attend
extramural teaching programs. Indeed, the percentage of
cases done off pump by the low adopters in the last 2 years
of the study actually declined, from 16% in 1999 to 9.6% in
2000. If so, are surgeons likely to adopt OFFCAB in a group
where no one is enthusiastic about it? I base this question on
the observation that among the 4 operating surgeons in our
own group, the current use of OFFCAB ranges from 3% to
50%.
Question 2 has broad implications, because it is the
patients operated on too early, not the surgeons, who really
experience the “learning curve.” When OFFCAB was first
introduced, many centers carried out postoperative angiog-
raphy routinely, and there was an undesirable incidence of
reoperation. In the study of Mack and associates,3 however,
it does appear that there was no significant learning curve,
because there was no observable trend toward lower mor-
tality and morbidity as the study progressed. This observa-
tion is both remarkable and commendable. Selection of
patients for OFFCAB was at the discretion of the individual
surgeon, and an observable learning curve was probably
avoided by starting with straightforward single-graft cases
and only progressing to multivessel cases after techniques
were refined. This combination of good clinical judgment
and technical expertise, which seems to have characterized
the high adopters, offers a valuable lesson about how to
adopt a new and difficult technique, but this approach has
not been equally successful everywhere.
The answer to question 3 is not available from this study.
Although the Mack and associates3 assert that “gradual
adoption and integration of beating-heart surgery, as re-
flected in the last 2 years of the study, led to a trend toward
overall improved CABG outcomes,” this conclusion is sus-
pect for various reasons. First, during the years of this study,
as throughout the history of cardiac surgery, there were
many refinements in surgical technique, anesthetic manage-
ment, drug therapy, hemostasis, arterial grafting techniques,
and so on. In an uncontrolled, retrospective study, any
improvement, even if statistically significant (which this is
not), would be the result of a combination of several factors
in addition to, or even aside from, the introduction of
OFFCAB. Second, if “high-risk” patients (more about risk
later) were preferentially treated off pump, most would have
been operated on by high adopters, who had the lowest
mortality rates even before the introduction of OFFCAB.
Progressive diversion of high-risk patients to those surgeons
could explain a slight trend toward overall improved CABG
outcomes.
Particularly relevant to this concern is a previous presen-
tation of combined experience by the Dallas and the Wash-
ington Hospital Center groups at the 2001 meeting of the
STS.4 They reported early mortality rates similar to those of
the study of Mack and associates3 (1.8% off pump vs 3.5%
on pump) and concluded that there were “consistent find-
ings of increased early mortality associated with cardiopul-
monary bypass.”4 In answer to questions during the discus-
sion period about the possibility that surgeons performing
the off-pump cases “represent a skilled group that might
achieve technically superior results in all patients,” the
authors acknowledged that the possibility was “intriguing”
but also “difficult to assess and politically charged.”4 It is
therefore all the more commendable that, despite such dif-
ficulties, they have now analyzed this possibility. We can
see that it was necessary to do so, because even the small
demonstrable benefit of OFFCAB may not be due entire-
ly—or even principally—to the technique itself.
Question 4 directly addresses this central issue of the
influence of the individual surgeon on the success of the
technique. Mack and associates3 acknowledge that “the
outcome improvement observed with off-pump surgery was
not due solely to the technique and that the individual
surgeon may have played a significant role.” The effect of
this phenomenon may be even greater than it seems, as is
apparent if one compares the results of on-pump CABG
(ONCAB) in this study with the benchmark results in the
STS database. I will use 1998 and 1999 data from the STS
database, because those years fall in the middle of this
5-year study and have already been analyzed and reported
with separate data for OFFCAB and ONCAB.5
The overall risk-adjusted mortality rate for ONCAB in
the report of Mack and associates3 was 3.9%, which is
significantly greater than the risk-adjusted mortality rate of
2.9% in the STS database. In contrast, the risk-adjusted
mortality for OFFCAB in this report was 1.9%, which is
lower than the 2.3% in the STS database. In part these
disparities may be due to the inaccuracy of using the same
risk-adjustment model for two disparate techniques such as
OFFCAB and ONCAB, as discussed later. More important,
these disparities reinforce the observation that the surgeons
capable of better results than the national averages were
primarily doing OFFCAB procedures. These high adopters
may also have been more comfortable with arterial grafting,
which would explain the increased use of arterial grafts in
OFFCAB cases and may have contributed to the mortality
disparities, because arterial grafting is associated with re-
duced operative mortality. Unequal case allocation could
also explain why the rate of reoperation for bleeding in
patients undergoing ONCAB (3.4%) was higher than the
STS database rate (2.9%), and why prolonged ventilation
was necessary in 10.5% of ONCAB cases, compared with
6.5% in the STS database.
This concern about differences in surgical expertise is
applicable to any comparison of OFFCAB and ONCAB that
does not have the same surgeons doing all the operations. It
even applies to the previously mentioned report from the
Editorials Bonchek





STS database,5 which found lower mortality and morbidity
with OFFCAB. Because the STS database does not adjust
for the experience and expertise of the surgeons who use
one technique or another, nor for the subjective criteria
surgeons use in selecting cases for OFFCAB, unexplained
biases may subtly influence its comparison of the two tech-
niques.
This brings us to question 5, and the complex issue
alluded to earlier of assessing the results of OFFCAB with
previously derived models for risk adjustment. No risk-
adjustment model can identify all confounding variables,
and there are always some unidentified confounders in any
model; it can only be hoped that they are unimportant.
However, the STS model was developed in a cohort of
patients that had ONCAB in 1994 and 1995, and it is
reasonable to suggest that it missed confounding variables
that are unique to OFFCAB and could affect mortality,
morbidity, and the selection of patients for OFFCAB. These
include the presence of intramyocardial coronary arteries;
diffuse coronary disease with small, poor-quality target
vessels; aortic atherosclerosis that precludes a side-biting
clamp for proximal anastomoses; left ventricular hypertro-
phy, which makes it hard to position the heart; and other
factors. The role of the surgeon’s experience and expertise
must also be analyzed. Most of the necessary data are not
being collected, and some probably cannot be, because they
are highly subjective and impossible to compare among
different institutions. Even if we had the data, it would take
years to weight them properly. Any new risk-adjustment
model for OFFCAB that included relevant variables would
require a new analysis to validate the model.
Clearly, because the importance of so many variables is
not and cannot be known, the conclusions of nonrandom-
ized, experiential reports will always be suspect. For exam-
ple, the STS database report concluded that OFFCAB sig-
nificantly reduced postoperative length of stay from 6.97 to
6.14 days, the incidence of prolonged mechanical ventila-
tion from 6.51% to 4.13%, and the risk-adjusted operative
mortality from 2.9% to 2.3%. Yet in our own group, the
ONCAB, risk-adjusted numbers for those years are as fol-
lows: length of stay 6.1 days, prolonged mechanical venti-
lation 3.7%, and risk-adjusted mortality 1.1%. Should we
realistically anticipate statistically significant improvement
if we aggressively adopt OFFCAB, or should we continue to
refine our reported techniques6,7 and use OFFCAB only in
selected circumstances?
Randomized studies are therefore essential, because they
eliminate the problems of risk adjustment and can be de-
signed so that all operations are done by the same surgeons.
Of course, it must be emphasized that randomized studies
are not a panacea; they still rely on subjective surgical
judgments, which may not be generalizable to all institu-
tions. The first such study, carried out at three hospitals in
the Netherlands by pioneers in OFFCAB, has recently been
reported.8 A total of 281 patients were randomly allocated
after they had been judged suitable for either technique, and
all surgeons were “experienced in both off pump and on
pump bypass surgery.”8 Although all patients had sternot-
omy, the patients and cardiologists were not blinded to
treatment group. At 30 days’ follow-up, there were no
differences in mortality, intensive care unit stay, stroke,
atrial fibrillation, myocardial infarction, use of blood prod-
ucts, quality of life, and hospital cost—parameters that
might have been expected to benefit from OFFCAB. The
only significant improvements with OFFCAB were less
release of creatine kinase isoenzyme MB and shorter post-
operative stay (6 days for OFFCAB vs 7 days for ONCAB).
Because OFFCAB was done with clamping of single coro-
nary arteries, whereas ONCAB was done with crystalloid
cardioplegia and global ischemia, the difference in enzyme
release is understandable. It is also unimportant, because
ONCAB can also be done with single-vessel occlusion, or
with intermittent global ischemia without cardioplegia.6,7
OFFCAB patients did average 1 day less hospitalization,
but readiness for discharge is a highly subjective decision
that could have been biased by the lack of blinding. Another
randomized study was carried out by a single surgeon (John
Puskas at Emory University), in which patients and nonop-
erative caregivers were blinded.9 Once again, there was
significantly less release of myocardial enzyme in the OFF-
CAB group, the OFFCAB group length of stay was 1 day
shorter, and the OFFCAB group received fewer transfu-
sions. But results were otherwise the same in the two
groups.
These remarks should not be misinterpreted as an argu-
ment that OFFCAB is not a useful technique. On the con-
trary, it is certainly advantageous in such circumstances as
for older patients with renal or pulmonary disease, and
undoubtedly in many others. It is important to remember,
however, that thus far it has only been shown to be better
than ONCAB for noncritical end points in selected patients
in the hands of selected surgeons. That there are differences
in surgical skill among surgeons is something that we all
know (else why would we travel so far to watch live
surgical demonstrations by recognized technical masters?)
but never discuss publicly. After all, if we did not have
confidence in ourselves, we could not go to work in the
morning. Until now, disparities in skill have been most
salient in regard to uncommon or extraordinarily challeng-
ing operations, such as thoracoabdominal aneurysms and
Ross procedures, and most surgeons have had the self-
awareness and common sense to avoid or to refer elective
operations they were not comfortable performing. But will
that self-restraint remain in force when it is needed for the
adult cardiac surgeon’s bread-and-butter procedure—
CABG? These admittedly unsettling considerations are
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mentioned because a technically demanding operation is
being offered in place of a remarkably successful, exhaus-
tively studied, and consistently reproducible procedure per-
formed by a vast cadre of trained, experienced surgeons. If
the use of OFFCAB is to be extended to more patients and
to all surgeons, it is essential to demonstrate, with properly
designed risk models and/or randomized studies, that OFF-
CAB offers benefits to those patients at the hands of all
surgeons. We are waiting eagerly for the evidence.
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